A three-dimensional approach for understanding the spectrum of idiopathic inflammatory demyelinating disorders: importance of the 'attack-related severity' axis

被引:2
作者
Fukazawa, T.
Kikuchi, S.
机构
[1] Nishimaruyama Hosp, Chuo Ku, Sapporo, Hokkaido 0648557, Japan
[2] Hokkaido Univ, Grad Sch Med, Dept Neurol, Kita Ku, Sapporo, Hokkaido 0638638, Japan
关键词
fulminant attack; idiopathic inflammatory demyelinating disorders; immunogenetic background; Japanese; multiple sclerosis; neuromyelitis optica; opticospinal MS;
D O I
10.1177/1352458506070689
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Understanding the spectrum of idiopathic inflammatory demyelinating disorders (IIDD) of the central nervous system is an important issue for accurate diagnosis and advancing research on the pathogenesis as well as treatment strategies, but the nosology and the classification of the IIDD remains confusing. Until now, we have tried to apply each disorder within the spectrum to an adequate co-ordinate on a two-dimensional plane. One axis is clinical course and the other is lesion distribution. We reviewed some disorders of the IIDD spectrum, and our recent findings on the fulminant nature of each attack and the expansion of each lesion, which we called attack-related severity in Japanese multiple sclerosis (MS). From our findings and the literature, attack-related severity appears to be a third important factor, in addition to lesion distribution and clinical course. Introduction of the third axis produces a three-dimensional space for a better understanding of the heterogeneous characteristics of IIDD and 'MS' syndrome, and can advance treatment strategies for these disorders. As severe attacks seem to be relatively common in Asians but rare in the west, ethnic-related heterogeneity should be considered in understanding the spectrum of IIDD, and there is an urgent need to develop a common general concept of the spectrum, especially for MS.
引用
收藏
页码:199 / 207
页数:9
相关论文
共 70 条
[1]   Acute transverse myelitis - A localized form of postinfectious encephalomyelitis [J].
AlDeeb, SM ;
Yaqub, BA ;
Bruyn, GW ;
Biary, NM .
BRAIN, 1997, 120 :1115-1122
[2]   Differentiation of multiple sclerosis subtypes -: Implications for treatment [J].
Bitsch, A ;
Brück, W .
CNS DRUGS, 2002, 16 (06) :405-418
[3]  
CHONG HT, 2002, NEUROL J SE ASIA, V7, P35
[4]   Recurrence of acute disseminated encephalomyelitis at the previously affected brain site [J].
Cohen, O ;
Steiner-Birmanns, B ;
Biran, I ;
Abramsky, O ;
Honigman, S ;
Steiner, I .
ARCHIVES OF NEUROLOGY, 2001, 58 (05) :797-801
[5]   GENES AND SUSCEPTIBILITY TO MULTIPLE-SCLEROSIS [J].
COMPSTON, DAS ;
WOOD, HK ;
ROBERTSON, N ;
SAWCER, S ;
WOOD, NW .
ACTA NEUROLOGICA SCANDINAVICA, 1995, 91 :43-51
[6]   An open label study of the effects of rituximab in neuromyelitis optica [J].
Cree, BAC ;
Lamb, S ;
Morgan, K ;
Chen, A ;
Waubant, E ;
Genain, C .
NEUROLOGY, 2005, 64 (07) :1270-1272
[7]   Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis [J].
Cree, BAC ;
Khan, O ;
Bourdette, D ;
Goodin, DS ;
Cohen, JA ;
Marrie, RA ;
Glidden, D ;
Weinstock-Guttman, B ;
Reich, D ;
Patterson, N ;
Haines, JL ;
Pericak-Vance, M ;
DeLoa, C ;
Oksenberg, JR ;
Hauser, SL .
NEUROLOGY, 2004, 63 (11) :2039-2045
[8]   Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis [J].
de Seze, J ;
Lebrun, C ;
Stojkovic, T ;
Ferriby, D ;
Chatel, M ;
Vermersch, P .
MULTIPLE SCLEROSIS JOURNAL, 2003, 9 (05) :521-525
[9]   Devic's neuromyelitis optica:: study of nine cases [J].
Fardet, L ;
Généreau, T ;
Mikaeloff, Y ;
Fontaine, B ;
Seilhean, D ;
Cabane, J .
ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (03) :193-200
[10]   Antineutrophil cytoplasmic antibodies and the optic-spinal form of multiple sclerosis in Japan [J].
Fukazawa, T ;
Hamada, T ;
Kikuchi, S ;
Sasaki, H ;
Tashiro, K ;
Maguchi, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (02) :203-204